Autopsy and Case Reports
https://autopsyandcasereports.org/article/doi/10.4322/acr.2021.264
Autopsy and Case Reports
Clinical Case Report

Primary signet-ring cell carcinoma of the urinary bladder

Nirmalya Benerjee; Kalpesh Parmar; Kim Vaiphei

Downloads: 1
Views: 56

Abstract

Primary signet-ring cell carcinoma of the urinary bladder is a rare tumor. The overall incidence is approximately 0.12-0.6% of all urinary bladder malignancies. The majority of the patients present in an advanced stage with a uniformly grim prognosis. As signet-ring cell carcinomas are more common in the gastrointestinal tract, a possibility of metastasis needs to be considered. Here we report, a 42-year-old patient who presented with hematuria and was diagnosed with a urinary bladder tumor. The patient was managed with partial cystectomy and pelvic lymph node dissection. The histopathological examination confirmed primary signet-ring cell carcinoma of the urinary bladder.

Keywords

Cystectomy, Carcinoma, Signet-Ring Cell, Urinary Bladder

References

1 Saphir O. Signet-ring cell carcinoma of the urinary bladder. Am J Pathol. 1955;31(2):223-31. PMid:14350063.

2 Lendorf ME, Dohn LH, Dunga BA, Loya AC, Pappot H. An updated review on primary signet-ring cell carcinoma of the urinary bladder and report of a case. Scand J Urol. 2018;52(2):87-93. http://dx.doi.org/10.1080/21681805.2017.1418020. PMid:29291665.

3 Wang J, Wang FW. Clinical characteristics and outcomes of patients with primary signet-ring cell carcinoma of the urinary bladder. Urol Int. 2011;86(4):453-60. http://dx.doi.org/10.1159/000324263. PMid:21525723.

4 Nath V, Baliga M. Urinary bladder adenocarcinoma metastatic to the abdominal wall: report of a case with cytohistologic correlation. Case Rep Pathol. 2016;2016:8608412. http://dx.doi.org/10.1155/2016/8608412. PMid:27006847.

5 Wang J, Wang F, Kessinger A. The impact of signet-ring cell carcinoma histology on bladder cancer outcome. World J Urol. 2012;30(6):777-83. http://dx.doi.org/10.1007/s00345-011-0718-8. PMid:21706144.

6 Paner GP, Lopez-Beltran A, Sirohi D, Amin MB. Updates in the pathologic diagnosis and classification of epithelial neoplasms of urachal origin. Adv Anat Pathol. 2016;23(2):71-83. http://dx.doi.org/10.1097/PAP.0000000000000110. PMid:26849813.

7 Yamamoto S, Ito T, Akiyama A, et al. Primary signet‐ring cell carcinoma of the urinary bladder inducing renal failure. Int J Urol. 2001;8(4):190-3. http://dx.doi.org/10.1046/j.1442-2042.2001.00280.x. PMid:11260353.

8 Akamatsu S, Takahashi A, Ito M, Ogura K. Primary signet-ring cell carcinoma of the urinary bladder. Urology. 2010;75(3):615-8. http://dx.doi.org/10.1016/j.urology.2009.06.065. PMid:19819534.

9 Blute ML, Segura JW, Patterson DE, Benson RC Jr, Zincke H. Impact of endourology on diagnosis and management of upper urinary tract urothelial cancer. J Urol. 1989;141(6):1298-301. http://dx.doi.org/10.1016/S0022-5347(17)41286-9. PMid:2724425.

10 Fiter L, Gimeno F, Martin L, Gómez Tejeda L. Signet-ring cell adenocarcinoma of bladder. Urology. 1993;41(1):30-3. http://dx.doi.org/10.1016/0090-4295(93)90239-7. PMid:8380512.

11 Harik LR, O’Toole KM. Nonneoplastic lesions of the prostate and bladder. Arch Pathol Lab Med. 2012;136(7):721-34. http://dx.doi.org/10.5858/arpa.2011-0584-RA. PMid:22742546.

12 Hirano Y, Suzuki K, Fujita K, et al. Primary signet-ring cell carcinoma of the urinary bladder successfully treated with intra-arterial chemotherapy alone. Urology. 2002;59(4):601. http://dx.doi.org/10.1016/S0090-4295(01)01676-4. PMid:11927332.

13 Guan H, Tatsas AD, Ali SZ. Signet ring cell carcinoma in urine cytology: cytomorphologic findings and differential diagnosis. Acta Cytol. 2012;56(2):177-82. http://dx.doi.org/10.1159/000335118. PMid:22378081.

14 Thomas AA, Stephenson AJ, Campbell SC, Jones JS, Hansel DE. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder. Hum Pathol. 2009;40(1):108-16. http://dx.doi.org/10.1016/j.humpath.2008.06.022. PMid:18789486.

15 Fritsche HM, Burger M, Denzinger S, Legal W, Goebell PJ, Hartmann A. Plasmacytoid urothelial carcinoma of the bladder: histologic and clinical features of 5 cases. J Urol. 2008;180(5):1923-7. http://dx.doi.org/10.1016/j.juro.2008.07.035. PMid:18801525.

16 Amin MB, Smith SC, Eble JN, et al. Glandular neoplasms of the urachus: a report of 55 cases emphasizing mucinous cystic tumors with proposed classification. Am J Surg Pathol. 2014;38(8):1033-45. http://dx.doi.org/10.1097/PAS.0000000000000250. PMid:25025366.

17 Verma A, Tomar V. Signet ring cell carcinoma of urachal origin presenting as irritative lower urinary tract symptoms and pain abdomen: a rare case report. J Clin Diagn Res. 2016;10(7):PD12-3. http://dx.doi.org/10.7860/JCDR/2016/18851.8129. PMid:27630901.

18 Egevad L, Håkansson U, Grabe M, Ehrnström R. Urachal signet-cell adenocarcinoma. Scand J Urol Nephrol. 2009;43(1):88-91. http://dx.doi.org/10.1080/00365590802361914. PMid:18759168.

19 Pugashetti N, Yap SA, Lara PN Jr, Gandour-Edwards R, Dall’Era MA. Metastatic signet-ring cell carcinoma of the urinary bladder: a novel management approach to a rare tumor. Cuaj. 2015;9(3-4):E204-7. http://dx.doi.org/10.5489/cuaj.2447. PMid:26085880.

20 Erdoğru T, Kilicaslan I, Esen T, Ander H, Ziylan O, Uysal V. Primary signet-ring cell carcinoma of the urinary bladder: review of the literature and report of two cases. Urol Int. 1995;55(1):34-7. http://dx.doi.org/10.1159/000282745. PMid:7571182.

21 El Ammari JE, Ahsaini M, Riyach OEI, et al. Primary signet-ring cell carcinoma of the urinary bladder successfully managed with cisplatin and gemcitabine: a case report. J Med Case Rep. 2013;7(1):37. http://dx.doi.org/10.1186/1752-1947-7-37. PMid:23388175.
 


Submitted date:
09/08/2020

Accepted date:
02/11/2021

Publication date:
04/22/2021

6081dbd0a9539571b747ffd4 autopsy Articles
Links & Downloads

Autops Case Rep

Share this page
Page Sections